(3h)2-carbomethoxy-3-(4-fluorophenyl)tropane and benzyloxycarbonyl-isoleucyl-glutamyl(o-tert-butyl)-alanyl-leucinal

(3h)2-carbomethoxy-3-(4-fluorophenyl)tropane has been researched along with benzyloxycarbonyl-isoleucyl-glutamyl(o-tert-butyl)-alanyl-leucinal in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brownell, AL; McNaught, KS; Olanow, CW; Perl, DP	1

Other Studies

1 other study(ies) available for (3h)2-carbomethoxy-3-(4-fluorophenyl)tropane and benzyloxycarbonyl-isoleucyl-glutamyl(o-tert-butyl)-alanyl-leucinal

Article	Year
Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease. Annals of neurology, 2004, Volume: 56, Issue:1 Topics: Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Brain; Carbon Radioisotopes; Cocaine; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Dopamine Uptake Inhibitors; Hazardous Substances; Humans; Inclusion Bodies; Male; Molecular Structure; Multienzyme Complexes; Oligopeptides; Parkinson Disease, Secondary; Proteasome Endopeptidase Complex; Rats; Rats, Sprague-Dawley; Tomography, Emission-Computed	2004

Article

Year

Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease.

Annals of neurology, 2004, Volume: 56, Issue:1

Topics: Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Brain; Carbon Radioisotopes; Cocaine; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Dopamine Uptake Inhibitors; Hazardous Substances; Humans; Inclusion Bodies; Male; Molecular Structure; Multienzyme Complexes; Oligopeptides; Parkinson Disease, Secondary; Proteasome Endopeptidase Complex; Rats; Rats, Sprague-Dawley; Tomography, Emission-Computed

2004